158 related articles for article (PubMed ID: 14499174)
1. Endothelium activation in the anti-phospholipid syndrome.
Raschi E; Testoni C; Borghi MO; Fineschi S; Meroni PL
Biomed Pharmacother; 2003 Sep; 57(7):282-6. PubMed ID: 14499174
[TBL] [Abstract][Full Text] [Related]
2. Endothelial cell activation by antiphospholipid antibodies.
Meroni PL; Raschi E; Testoni C; Borghi MO
Clin Immunol; 2004 Aug; 112(2):169-74. PubMed ID: 15240160
[TBL] [Abstract][Full Text] [Related]
3. Innate immunity in the antiphospholipid syndrome: role of toll-like receptors in endothelial cell activation by antiphospholipid antibodies.
Meroni PL; Raschi E; Testoni C; Parisio A; Borghi MO
Autoimmun Rev; 2004 Nov; 3(7-8):510-5. PubMed ID: 15546799
[TBL] [Abstract][Full Text] [Related]
4. Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies.
Raschi E; Testoni C; Bosisio D; Borghi MO; Koike T; Mantovani A; Meroni PL
Blood; 2003 May; 101(9):3495-500. PubMed ID: 12531807
[TBL] [Abstract][Full Text] [Related]
5. Endothelium as a target for antiphospholipid antibodies.
Riboldi P; Gerosa M; Raschi E; Testoni C; Meroni PL
Immunobiology; 2003; 207(1):29-36. PubMed ID: 12638900
[TBL] [Abstract][Full Text] [Related]
6. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
Arnout J
Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
[TBL] [Abstract][Full Text] [Related]
7. Relationship between anti-phospholipid and anti-endothelial cell antibodies III: beta 2 glycoprotein I mediates the antibody binding to endothelial membranes and induces the expression of adhesion molecules.
Del Papa N; Guidali L; Spatola L; Bonara P; Borghi MO; Tincani A; Balestrieri G; Meroni PL
Clin Exp Rheumatol; 1995; 13(2):179-85. PubMed ID: 7544710
[TBL] [Abstract][Full Text] [Related]
8. Anti-β
Virachith S; Saito M; Watanabe Y; Inoue K; Hoshi O; Kubota T
Clin Exp Immunol; 2019 Feb; 195(2):167-178. PubMed ID: 30368780
[TBL] [Abstract][Full Text] [Related]
9. Endothelial cells as a target for antiphospholipid antibodies: role of anti-beta 2 glycoprotein I antibodies.
Del Papa N; Raschi E; Catelli L; Khamashta MA; Ichikawa K; Tincani A; Balestrieri G; Meroni PL
Am J Reprod Immunol; 1997 Sep; 38(3):212-7. PubMed ID: 9325495
[TBL] [Abstract][Full Text] [Related]
10. Endothelium as a target for anti-phospholipid antibodies and for therapeutical intervention.
Meroni PL; Raschi E; Testoni C
Autoimmun Rev; 2002 Feb; 1(1-2):55-60. PubMed ID: 12849059
[TBL] [Abstract][Full Text] [Related]
11. Pathogenic role of antiprotein-phospholipid antibodies.
Carreras LO; Forastiero RR
Haemostasis; 1996 Oct; 26 Suppl 4():340-57. PubMed ID: 8979139
[TBL] [Abstract][Full Text] [Related]
12. Antiphospholipid antibodies: specificity and pathophysiology.
de Groot PG; Oosting JD; Derksen RH
Baillieres Clin Haematol; 1993 Sep; 6(3):691-709. PubMed ID: 8025348
[TBL] [Abstract][Full Text] [Related]
13. Antiphospholipid antibodies as cause of pregnancy loss.
Meroni PL; di Simone N; Testoni C; D'Asta M; Acaia B; Caruso A
Lupus; 2004; 13(9):649-52. PubMed ID: 15485095
[TBL] [Abstract][Full Text] [Related]
14. Molecular pathogenesis of the antiphospholipid syndrome.
Rand JH
Circ Res; 2002 Jan; 90(1):29-37. PubMed ID: 11786515
[TBL] [Abstract][Full Text] [Related]
15. The prevalence of a non-phospholipid-binding form of beta2-glycoprotein I in human plasma--consequences for the development of anti-beta2-glycoprotein I antibodies.
Horbach DA; van Oort E; Tempelman MJ; Derksen RH; de Groot PG
Thromb Haemost; 1998 Nov; 80(5):791-7. PubMed ID: 9843173
[TBL] [Abstract][Full Text] [Related]
16. [Antiphospholipid and anti beta 2-glycoprotein I antibodies].
Arvieux J; Roussel B; Colomb MG
Ann Biol Clin (Paris); 1994; 52(5):381-5. PubMed ID: 7856939
[TBL] [Abstract][Full Text] [Related]
17. Antiphospholipid antibodies bind to activated but not resting endothelial cells: is an independent triggering event required to induce antiphospholipid antibody-mediated disease?
Chen Q; Stone PR; Woon ST; Ching LM; Hung S; McCowan LM; Chamley LW
Thromb Res; 2004; 114(2):101-11. PubMed ID: 15306152
[TBL] [Abstract][Full Text] [Related]
18. Pathogenic role of anti-beta 2-glycoprotein I antibodies in antiphospholipid associated fetal loss: characterisation of beta 2-glycoprotein I binding to trophoblast cells and functional effects of anti-beta 2-glycoprotein I antibodies in vitro.
Di Simone N; Raschi E; Testoni C; Castellani R; D'Asta M; Shi T; Krilis SA; Caruso A; Meroni PL
Ann Rheum Dis; 2005 Mar; 64(3):462-7. PubMed ID: 15256379
[TBL] [Abstract][Full Text] [Related]
19. Beta2-glycoprotein I as a 'cofactor' for anti-phospholipid reactivity with endothelial cells.
Meroni PL; Del Papa N; Raschi E; Panzeri P; Borghi MO; Tincani A; Balestrieri G; Khamashta MA; Hughes GR; Koike T; Krilis SA
Lupus; 1998; 7 Suppl 2():S44-7. PubMed ID: 9814672
[TBL] [Abstract][Full Text] [Related]
20. Pathogenesis of antiphospholipid antibodies: impairment of fibrinolysis and monocyte activation via the p38 mitogen-activated protein kinase pathway.
Yasuda S; Bohgaki M; Atsumi T; Koike T
Immunobiology; 2005; 210(10):775-80. PubMed ID: 16325497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
